Shorr Robert G L - Net Worth and Insider Trading
Shorr Robert G L Net Worth
The estimated net worth of Shorr Robert G L is at least $2,234 dollars as of 2024-11-13. Shorr Robert G L is the Director of Brainstorm Cell Therapeutics Inc and owns about 1,893 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $2,234. Details can be seen in Shorr Robert G L's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shorr Robert G L has not made any transactions after 2015-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shorr Robert G L
Shorr Robert G L Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shorr Robert G L owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of Shorr Robert G L’s form 4 insider trades.
Insider Ownership Summary of Shorr Robert G L
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BCLI | Brainstorm Cell Therapeutics Inc | 2015-12-16 | director |
Shorr Robert G L Latest Holdings Summary
Shorr Robert G L currently owns a total of 1 stock. Shorr Robert G L owns 1,893 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of December 16, 2015, with a value of $2,234.
Latest Holdings of Shorr Robert G L
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
BCLI | Brainstorm Cell Therapeutics Inc | 2015-12-16 | 1,893 | 1.18 | 2,234 |
Holding Weightings of Shorr Robert G L
Shorr Robert G L Form 4 Trading Tracker
According to the SEC Form 4 filings, Shorr Robert G L has made a total of 0 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years. The most-recent trade in Brainstorm Cell Therapeutics Inc is the sale of 720 shares on December 16, 2015, which brought Shorr Robert G L around $29,268.
Insider Trading History of Shorr Robert G L
- 1
Shorr Robert G L Trading Performance
Shorr Robert G L Ownership Network
Ownership Network List of Shorr Robert G L
Ownership Network Relation of Shorr Robert G L
Shorr Robert G L Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
Shorr Robert G L is the director of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, Shorr Robert G L made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
Shorr Robert G L Mailing Address
Above is the net worth, insider trading, and ownership report for Shorr Robert G L. You might contact Shorr Robert G L via mailing address: 28 Brookfall Rd., Edison Nj 08817.